FluroTech

February 4, 2021

BRIAN SHIELD, BOSTON RED SOX VP OF IT, JOINS FLUROTECH ADVISORY BOARD

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of COVID-19 and other pathogens, today announced that Brian…...
Read More
February 3, 2021

FluroTech Provides Executive Update on Program Advancements

FluroTech Ltd (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a lead ing developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of COVID-19 and other pathogens, today announced that…...
Read More
January 21, 2021

FLUROTECH ANNOUNCES CLOSING OF OVERSUBSCRIBED $2.5 MILLION PRIVATE PLACEMENT FINANCING AND ANNOUNCES COMMUNICATIONS ENGAGEMENT FOR INVESTOR RELATIONS SERVICES

Calgary, Alberta, January 21, 2021 – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the Offering”). 15,644,844 Units…...
Read More